Skip to main content
    P

    Protagonist Therapeutics Inc (PTGX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $124.67
    -0.16 (-0.13%)

    Market Cap: $8.55B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Protagonist Therapeutics Inc (PTGX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Protagonist Therapeutics (PTGX) has a latest price of $124.67 on Nov 17, 2026, 22.5% below its 52-week high of $160.81. Its price rose 47.3% over the past 12 months. The month-end price rose 670.5% over the 10 years through Oct 2026, a compound annual rate of 22.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $147.75 in Aug 2026 and its lowest $6.47 in Nov 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PTGX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PTGX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 19.5%, and over 6 months it rose 26.7%. The month-end price rose 896.2% over the 3 years through Oct 2026, a compound annual rate of 115.2%.

    PeriodChange
    1 month-7.3%
    3 months-19.5%
    6 months+26.7%
    12 months+47.3%
    12 months, with dividends+47.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+896.2%+115.2%
    5 years+364.9%+36.0%
    10 years+670.5%+22.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 186.0%, and its weakest was 2022, when it fell 68.1%.

    YearCloseChange
    2026 through Oct 2026$144.85+65.8%
    2025$87.34+126.3%
    2024$38.60+68.3%
    2023$22.93+110.2%
    2022$10.91-68.1%
    2021$34.20+69.6%
    2020$20.16+186.0%
    2019$7.05+4.8%
    2018$6.73-67.6%
    2017$20.80-5.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 10.6% below its 50-day average of $139.46 and 4.1% above its 200-day average of $119.71.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$124.67
    52-week high$160.81-22.5%
    52-week low$77.00+61.9%
    50-day average$139.46-10.6%
    200-day average$119.71+4.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 31.6%.

    MeasureValue
    1-year beta0.94
    Largest fall, 1 year-21.4%
    Largest fall, 3 years-31.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PTGX

    What is PTGX's 1-year price change?

    Protagonist Therapeutics's price rose 47.3% over the past 12 months. With dividends included, the 12-month total return was 47.3%.

    What is PTGX's 5-year price change?

    Protagonist Therapeutics's month-end price rose 364.9% over the 5 years through Oct 2026, a compound annual rate of 36.0%. These figures leave out dividends.

    What is PTGX's 52-week high and low?

    Protagonist Therapeutics's 52-week high is $160.81 and its 52-week low is $77.00. Its latest price of $124.67 on Nov 17, 2026 is 22.5% below the high.

    What is PTGX's beta?

    Protagonist Therapeutics's 1-year beta against the S&P 500 is 0.94, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 21.4%.

    Is the PTGX chart free?

    Yes. Advanced Charting for PTGX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.